Codman Neuro introduces new platform of embolic coils for treatment of brain aneurysms

Features Coil Shapes for Every Step of Procedure with New Delivery System

Codman Neuro, part of DePuy Synthes Companies of Johnson & Johnson, has introduced a new platform of embolic coils for the treatment of brain aneurysms, supported by an enhanced detachment system designed to improve microcatheter stability and provide an optimized detachment zone for coils. The announcement was made here at the Society of NeuroInterventional Surgery (SNIS) 12^th Annual Meeting.

The family of framing, filling and finishing coils used during a minimally invasive endovascular procedure is designed to help doctors individualize intervention based on the unique anatomy of the aneurysm. Offering coils designed for each step of the procedure may help clinicians achieve aneurysm stability, effective neck coverage and the packing density needed for treatment of brain aneurysms. Codman Neuro is the only company to offer coil shapes for each step of the procedure— MICRUSFRAME™ Coils for framing, GALAXY G3^™ Coils for filling, and DELTAXSFT™ Coils for finishing.

The enhanced detachment system provides the physician with improved microcatheter stability. Tactile fluoro markers on the delivery wire improve visibility and control during the procedure, potentially reducing X-ray exposure time for patients and hospital staff.

“The Codman Neuro family of coils and detachment system provide the best of both worlds; a softer detachment and three types of coils that help me individualize treatment based on the anatomy of the aneurysm,” said Ajit S. Puri, MD, Division of Neurointerventional Surgery at UMass Memorial Medical Center in Worcester, Mass. “Also, the new fluoro markers may help tactically navigate the procedure better.”

Brain aneurysms are weak spots on blood vessels that have the potential to rupture and cause bleeding within the brain. They can lead to serious complications, including hemorrhagic stroke, permanent nerve damage or death. According to the American Stroke Association, about 3 to 5 million people in the United States have cerebral aneurysms.

During a coiling procedure, tiny coils are deployed directly into the aneurysm in a minimally invasive interventional procedure using a microcatheter, to induce clotting or embolization and prevent rupture. The coils may be of various shapes, sizes and configurations and are deployed by the physician depending on the anatomy of the aneurysm.

The Codman Neuro family of coils features exclusive DELTAWIND^™ Technology. This coil technology was designed with hundreds of natural micro-deflection points so the coils can easily change direction, which allows the coils to seek and fill open spaces and be uniformly distributed to facilitate increased packing density. High packing densities have been correlated with low patient retreatment rates.

“Our coils are unique because they allow the physician to truly tailor the procedure at every step,” said P. Laxmin Laxminarain, Worldwide President of Codman Neuro. “Coupled with a new, softer delivery system, our coil platform is designed to improve how aneurysms are treated, and is an example of the continued commitment of Codman Neuro to innovation in neurovascular care.”